Rilutek (Covis Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Rilutek drug offered from Covis Pharmaceuticals, Inc.. This Benzothiazole [EPC],Benzothiazoles [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Covis Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | riluzole |
SUBSTANCE NAME: | RILUZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Benzothiazole [EPC],Benzothiazoles [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-07-15 |
END MARKETING DATE: | 0000-00-00 |
Rilutek HUMAN PRESCRIPTION DRUG Details:
Item Description | Rilutek from Covis Pharmaceuticals, Inc. |
LABELER NAME: | Covis Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 2013-07-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 24987-700_2f204d18-4ce2-43bf-8042-32e6e1ff8712 |
PRODUCT NDC: | 24987-700 |
APPLICATION NUMBER: | NDA020599 |
Other RILUZOLE Pharmaceutical Manufacturers / Labelers: